Clinical Trial Update: Vinorelbine and Docetaxel in Treating Women With Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating vinorelbine and docetaxel in women with metastatic breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Vinorelbine (Vinorelbine)

Snippet

Sponsor: Medstar Health Research Institute | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED